MDM2 and neoplasm: Specifically, SNP309G resides in the area of the MDM2 promoter that is bound by the estrogen receptor (Kinyamu and Archer, 2003) and the largest differences in age of tumor onset associated with the G/G genotype were seen in premenopausal women (Bond et al., 2006a; Bond and Levine, 2007).